Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lantheus Holdings (NQ: LNTH )

104.95 -0.23 (-0.22%)
Streaming Delayed Price Updated: 10:27 AM EDT, Oct 3, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Lantheus Holdings

< Previous 1 2 3 4 5 6 7 8 Next >
Despite its impressive fundamentals, NASDAQ:LNTH remains undervalued.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is an undervalued gem with solid fundamentals. 
Via Chartmill
Lantheus Downgraded Due To Reliance On PNT2002; Analyst Cites Comparable Profile To Novartis' Drug
Monday, Lantheus Holdings Inc (NASDAQ: LNTH) and POINT Biopharma Global Inc (NASDAQ: PNT) reported topline data from pivotal Phase 3 SPLASH trial of 177Lu-PNT2002 in metastatic c 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Why is Prostate Cancer Focused Lantheus Stock Trading Lower Today?
Lantheus Holdings Inc (NASDAQ: LNTH) and POINT Biopharma Global Inc (NASDAQ: PNT) reported topline data from pivotal Phase 3 SPLASH trial of 177Lu-PNT2002 in metastatic castration-res 
Via Benzinga
NASDAQ:LNTH—Positioned as a High-Growth Stock, Ready for a Potential Breakout.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH), a strong growth stock, setting up for a breakout. 
Via Chartmill
Unlocking the Growth Potential of NASDAQ:LNTH.
Is LANTHEUS HOLDINGS INC (NASDAQ:LNTH) suited for growth investing? 
Via Chartmill
The Latest Analyst Ratings for Lantheus Holdings
Via Benzinga
Why Lantheus Holdings Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Lantheus Holdings, Inc. (NASDAQ: LNTH) fell sharply during Monday’s session after the company and POINT Biopharma announced topline results from the pivotal phase 3 SPLASH study in metastatic... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Investors should take note of NASDAQ:LNTH, a growth stock that remains attractively priced.
Despite its growth, NASDAQ:LNTH remains within the realm of affordability. 
Via Chartmill
NASDAQ:LNTH is showing decent growth, but is still valued reasonably.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is showing decent growth, but is still valued reasonably. 
Via Chartmill
Exploring the Growth Potential of NASDAQ:LNTH as It Nears a Breakout.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH)—A High-Growth Stock Gearing Up for Its Next Upward Move. 
Via Chartmill
NASDAQ:LNTH, an undervalued stock with good fundamentals.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is probably undervalued for the fundamentals it is displaying. 
Via Chartmill
DexCom Stock Earns Healthy Relative Strength Rating Upgrade
In a welcome move, medical device maker DexCom stock saw its Relative Strength Rating rise from 70 to 77 on Tuesday. 
Via Investor's Business Daily
When you look at NASDAQ:LNTH, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is a prime example of a stock that offers more than what meets the eye in terms of fundamentals. 
Via Chartmill
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
For those who appreciate growth without the sticker shock, NASDAQ:LNTH is worth considering.
Despite its growth, NASDAQ:LNTH remains within the realm of affordability. 
Via Chartmill
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
In the world of growth stocks, NASDAQ:LNTH shines as a value proposition.
Looking for growth without the hefty price tag? Consider NASDAQ:LNTH. 
Via Chartmill
4 Analysts Have This to Say About Lantheus Holdings
Via Benzinga
7 Low-Risk Stock Picks to Double Your Money
As we get closer to the new year, investors may want to consider these top, low-risk stocks to double your money. 
Via InvestorPlace
Don't overlook NASDAQ:LNTH—it's a hidden gem with strong fundamentals and an attractive price tag.
LANTHEUS HOLDINGS INC (NASDAQ:LNTH) is an undervalued gem with solid fundamentals. 
Via Chartmill
7 Small-Cap Stocks to Buy Before the Next Recession Hits
These small-cap stocks look like a strong buys based on historical trends that favor the class of equities in the lead up to a downturn. 
Via InvestorPlace
Topics Economy
Exposures Economy
Stock Market Ends On High Note Even As Yields Soar; Tesla In Focus: Weekly Review
A rally attempt continues amid soaring Treasury yields. 
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Why Shares of Point Biopharma Global Are Soaring Tuesday
The company entered into a buyout agreement with Eli Lilly. 
Via The Motley Fool
Why Getty Images Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Vericity, Inc. (NASDAQ: VERY) shares climbed 87.4% to $11.12 after iA Financial Group announced it will acquire the company. 
Via Benzinga
Vericity, POINT Biopharma Global, Oddity Tech And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Nasdaq Composite falling more than 100 points on Tuesday. Here are some big stocks recording gains in today’s session. Vericity, Inc. (NASDAQ: VERY) shares climbed... 
Via Benzinga
Topics Stocks
Exposures US Equities
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.